MedTrace Logo

A Study to Evaluate the Safety and Pharmacokinetics of AZD7760 in Healthy Japanese Adults

NCT07612813 · Status: NOT_YET_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2026-05-29

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and PK of AZD7760 when given as an intravenous (IV) infusion to healthy Japanese adult participants.

Conditions

  • Staphylococcus Aureus Bloodstream Infection

Interventions

DRUG

AZD7760

Participants will receive AZD7760 via IV infusion.

OTHER

Placebo

Participants will receive matching placebo via IV infusion.

Sponsors & Collaborators

  • Parexel

    collaborator INDUSTRY

  • AstraZeneca

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-06-24
Primary Completion
2027-09-24
Completion
2027-09-24

Countries

  • Japan

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07612813 on ClinicalTrials.gov